GE HealthCare Technologies Inc.·4

Feb 17, 7:17 PM ET

O'Neill Kevin Michael 4

Research Summary

AI-generated summary

Updated

GE HealthCare CEO Kevin O'Neill Receives Award, 6,938 Shares

What Happened

  • Kevin Michael O'Neill, CEO of GE HealthCare Technologies Inc., had performance stock units (PSUs) vest on Feb 12, 2026. The vesting converted to 6,938 shares of GE HealthCare common stock (recorded as an award/acquisition at $0.00 per share).
  • To satisfy tax withholding, 3,261 of those shares were withheld and disposed at an effective per-share value of $79.20, totaling $258,271. The PSUs were originally granted on March 1, 2023, and the applicable performance criteria were certified before vesting.

Key Details

  • Transaction date: February 12, 2026 (vesting date). Filing date: February 17, 2026 (Form 4 accession 0001951605-26-000004). The filing date appears timely under the SEC’s 2-business-day rule (Feb 16 was a federal holiday).
  • Award: 6,938 shares acquired (code A) at $0.00 — conversion of PSUs into common stock.
  • Tax withholding: 3,261 shares withheld/disposed (code F) at $79.20 per share = $258,271 withheld to cover taxes.
  • Footnotes: PSUs were granted March 1, 2023; performance criteria were met and PSUs vested Feb 12, 2026 (F1). Share withholding satisfied tax obligations related to the vesting (F2).
  • Shares owned after the transaction: not specified in the filing.

Context

  • This is a compensation vesting event (PSUs converting to shares), not an open-market buy or sale that signals a trading decision. The withholding of shares to cover taxes is a common administrative step that reduces the net shares the insider receives.